Statement
6 Jun 2023
G20 side event on “Envisaging a Global R&D Network for Research in Vaccines, Therapeutics, and Diagnostics (VTDs) to enhance Prevention, Preparedness, and Response (PPR)”
On 6 June, IFPMA delivered a statement at the G20 “Strengthening Global Collaboration on Research and Development in MCMs (Diagnostics, Vaccines, and Therapeutics” side event on “Envisaging a Global R&D Network for Research in VTDs to enhance PPR” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read more
Statement
5 Jun 2023
G20 side event on Global Vaccine Research Collaborative
On 3 June, IFPMA delivered a statement at the PATH and CEPI side event on the “Global Vaccine Research Collaborative” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read more
Position paper
27 Mar 2023
No-Fault Compensation (NFC) systems and legislative liability protections for pandemic vaccines
This joint white paper recommends the implementation of well-designed NFC systems coupled with legislative liability protections for pandemic vaccines to ensure both equitable compensation and adequate vaccine coverage in a future pandemic.
Read more
